Navigation Links
Blood Clots During Pregnancy More Likely After IVF, Study Says
Date:1/16/2013

By Steven Reinberg
HealthDay Reporter

TUESDAY, Jan. 15 (HealthDay News) -- Women who became pregnant through in vitro fertilization (IVF) may have an increased risk of developing blood clots and potentially fatal artery blockage, Swedish investigators suggest.

Although the risk remains small, the odds are especially high during the first trimester compared to women who become pregnant naturally, the researchers said.

Blood clots -- called venous thromboembolism -- can develop in the leg veins and break free, traveling to the lungs and blocking a main artery. This condition, called pulmonary embolism, can cause difficulty breathing and even death.

"There is an increased incidence of pulmonary embolism and venous thrombosis among women pregnant after IVF," said lead researcher Dr. Peter Henriksson, a professor of internal medicine at the Karolinska Institute in Stockholm. "Embolism is the leading cause of maternal mortality during pregnancy. The diagnosis can be elusive, so physicians should be aware of this risk to facilitate the diagnosis."

The risk of clotting during pregnancy isn't confined to women who undergo IVF, another experts said.

"Any pregnancy carries a risk of clotting," said Dr. Avner Hershlag, chief of the Center for Human Reproduction at North Shore University Hospital in Manhasset, N.Y.

This is because hormones, particularly estrogen, increase during pregnancy, Hershlag said. "This changes what we call the clotting cascade," he said. "There are many factors in blood clotting that can be affected by hormones -- especially estrogen."

In addition, the enlarging uterus puts pressure on pelvic blood vessels, which can lead to clotting. Some women are advised to limit their movement to reduce the risk of clotting, Hershlag noted.

Although it's unclear why women who undergo IVF have a greater risk of clotting, Hershlag speculates that it could be due to fertility treatment
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. US Drug Watchdog Now Offers To Help All DePuy Pinnacle All Metal Hip Implant Recipients get to the Best Law Firms If A Blood Test Reveals Elevated Metal Levels
2. Surgical-site infections may increase risk of deadly blood clots after colorectal surgery
3. Blood cell researcher wins science academys 2013 Gottschalk Medal
4. US Drug Watchdog Now Urges All 500,000 US Recipients Of A Metal on Metal Hip Implant To Get A Blood Test for Elevated Levels Of Cobalt and Chromium
5. Smoking, high blood pressure and cholesterol can be fatal for hemorrhage survivors
6. US Drug Watchdog Now Puts a New Emphasis on DePuy Pinnacle Hip Implant Recipients and They Urge Them to Get a Blood Test for Elevated Metals Levels
7. Blood Pressure Monitoring and Measurement Instruments Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
8. Blood Disorder Cases Tied to Prescription Painkiller Abuse
9. This week in Blood: Jan. 10, 2013
10. US Drug Watchdog Now Urges DePuy Pinnacle Metal Hip Recipients To Get A Blood Test and to Call Them For The Names Of The Best Lawyers If Their Metals Levels Are Elevated
11. Microscopic blood in urine unreliable indicator of urinary tract cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Clots During Pregnancy More Likely After IVF, Study Says
(Date:4/20/2014)... its potentially harmful effects in children, codeine continues to ... research from UCSF Benioff Children,s Hospital San Francisco. , ... , solutions include changing provider prescription behaviors to promote ... ibuprofen or hydrocodone. , "Despite strong evidence against the ... be prescribed to large numbers of them each year," ...
(Date:4/18/2014)... 2014) -- A group of scientists from the ... Sanders-Brown Center on Aging has found interesting new ... function in Parkinson,s disease (PD). , Published ... study, which assessed cognitive function in depressed and ... replacement therapy commonly used to treat motor symptoms ...
(Date:4/18/2014)... have made a discovery that turns 160 years of ... material long known to be essential for the fast ... is not as ubiquitous as thought, according to a ... Harvard Stem Cell Institute (HSCI) and the University,s Department ... Professor Jeff Lichtman, of Harvard,s Department of Molecular and ...
(Date:4/18/2014)... (Seattle, WA April 18, 2014) Benaroya Research ... to research how blocking a particular molecule in metastatic ... and the number of lung metastases. BRI scientists have ... protein can shrink tumors by 60 - 80 percent ... to the lung. The $1.8 million five-year grant comes ...
(Date:4/18/2014)... . A ... A team led by Ludwik Leibler from the Laboratoire ... Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits Paris ... principle of adhesion by aqueous solutions of nanoparticles can ... tissues. This easy-to-use gluing method has been tested on ...
Breaking Medicine News(10 mins):Health News:UCSF study finds codeine often prescribed to children, despite available alternatives 2Health News:Treating depression in PD patients: New research 2Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3
... Confirms Part D Seniors Also Enjoy Broad Choice of,Prescription ... Association (PCMA) issued the following statement on new budget,figures ... is lower over the,next ten years than was estimated ... without sacrificing beneficiaries,choice of prescription drugs. New budget documents ...
... Nursing Home Care to Face,Severe Resistance, JOPLIN, Mo., ... today reporting the Bush Administration plans to cut,U.S. seniors, ... to,be unveiled Monday, the Coalition to Protect Senior Care ... as it did last summer and fall when the,Coalition ...
... Mettler-Toledo,International Inc. (NYSE: MTD ) today announced ... fourth-quarter results on Thursday, February,7, 2008 at 5:00 p.m. ... call,visit http://www.mt.com/investors on the Company,s website. A ... 2008., METTLER TOLEDO is a leading global supplier ...
... off Sponsorship of Living ... Aid Retired NFL Players, PHOENIX, Jan. 31 Retired ... are more than twice as likely,as the general population to ... stroke and other cardiovascular (CV) diseases, according to,a recent study ...
... Ill., Jan. 31 Horace Mann,Educators Corporation (NYSE: ... Wednesday, February 6, 2008 after the market closes. The,earnings ... Relations section of the Company,s website at http://www.horacemann.com ... financial results on,Thursday, February 7, 2008 at 10:00 a.m. ...
... 31 National opinion leaders will,convene in Arlington, ... data,guidelines, practical applications, and strategies for the treatment ... make the,meeting highly interactive., The Summit will ... sponsored,by The Dannemiller Educational Foundation, and the content ...
Cached Medicine News:Health News:Coalition to Protect Senior Care Gearing Up to Fight Bush Administration Medicare Cuts 2Health News:NFL Linemen Predisposed to Cardiovascular Disease; Early Detection is Key to Getting and Staying Healthy 2Health News:NFL Linemen Predisposed to Cardiovascular Disease; Early Detection is Key to Getting and Staying Healthy 3Health News:Horace Mann Announces Fourth Quarter Earnings Release and Conference Call 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than an Oreo ... to self-inject prescription drugs in the large doses required to ... autoimmune deficiencies, and genetic disorders.  An emerging ... 2018, according to analysts.   Many of these drugs will require ...
(Date:1/14/2014)... (Nasdaq: LMNX ) today announced that it expects ... Monday, February 3, 2014. A press release announcing the results ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the fourth quarter and twelve months ended ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 The Brandeis Medical Center, ... Angeles a premier and affordable laser tattoo removal experience ... Dr. Brandeis, focus is in providing high quality cosmetic services with ... patients. " Southern California has seen ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... -,Phytopharm plc (LSE: PYM) ("Phytopharm" or the ... reverses the,changes in the area of the ... be presented by Dr Jonathan Brotchie, an,internationally ... International Congress of Parkinson's Disease and Movement,Disorders' ...
... UVIDEM was well-tolerated with signs of durable,disease control ... 05, 2007 /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. today presented ... vaccine clinical trial (DC-MEL-202). The,results showed that UVIDEM ... of immune response in patients with,progressive metastatic melanoma. ...
Cached Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: